Literature DB >> 24508408

Adrenal insufficiency in a child with MELAS syndrome.

Bushra Afroze1, Nida Amjad1, Shahnaz H Ibrahim2, Khadija Nuzhat Humayun1, Yusnita Yakob3.   

Abstract

Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) are established subgroups of mitochondrial encephalomyopathy. m.3243A>G a common point mutation is detected in tRNA in majority of patients with MELAS phenotype whereas m.8344A>G point mutation in tRNA is observed, in MERRF phenotype. Adrenal insufficiency has not been reported in mitochondrial disease, except in Kearns-Sayre Syndrome (KSS), which is a mitochondrial deletion syndrome. We report an unusual presentation in a five year old boy who presented with clinical phenotype of MELAS and was found to have m.8344A>G mutation in tRNA. Addison disease was identified due to hyperpigmentation of lips and gums present from early childhood. This is the first report describing adrenal insufficiency in a child with MELAS phenotype.
Copyright © 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenal insufficiency; Endocrinopathy; MELAS; Mitochondriopathy

Mesh:

Substances:

Year:  2014        PMID: 24508408     DOI: 10.1016/j.braindev.2013.12.009

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  7 in total

Review 1.  An overview of inborn errors of metabolism manifesting with primary adrenal insufficiency.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

2.  Sideroblastic anaemia and primary adrenal insufficiency due to a mitochondrial respiratory chain disorder in the absence of mtDNA deletion.

Authors:  Michael J O'Grady; Ahmad A Monavari; Melanie Cotter; Nuala P Murphy
Journal:  BMJ Case Rep       Date:  2015-02-26

Review 3.  Mitochondrial disease and endocrine dysfunction.

Authors:  Jasmine Chow; Joyeeta Rahman; John C Achermann; Mehul T Dattani; Shamima Rahman
Journal:  Nat Rev Endocrinol       Date:  2016-10-07       Impact factor: 43.330

4.  Commentary: New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the MT-ND4 Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Autoimmune Syndrome Type 2.

Authors:  Josef Finsterer
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

5.  New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the MT-ND4 Gene (m.12015T>C; p.Leu419Pro) and Comorbid Polyglandular Autoimmune Syndrome Type 2.

Authors:  Dominique Endres; Patrick Süß; Simon J Maier; Evelyn Friedel; Kathrin Nickel; Christiane Ziegler; Bernd L Fiebich; Franz X Glocker; Friedrich Stock; Karl Egger; Thomas Lange; Michael Dacko; Nils Venhoff; Daniel Erny; Soroush Doostkam; Katalin Komlosi; Katharina Domschke; Ludger Tebartz van Elst
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

6.  Delay in diagnosing a patient with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome who presented with status epilepticus and lactic acidosis: a case report.

Authors:  Ahmad F Alenezi; Mariam A Almelahi; Feten Fekih-Romdhana; Haitham A Jahrami
Journal:  J Med Case Rep       Date:  2022-10-10

7.  Rare Phenotypic Manifestations of MELAS.

Authors:  Josef Finsterer
Journal:  Yonsei Med J       Date:  2020-10       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.